These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 4040360)

  • 1. Characterisation of rat tumour cell hybrids: procoagulant and fibrinolytic activities.
    Badenoch-Jones P; Ramshaw IA
    Aust J Exp Biol Med Sci; 1985 Feb; 63 ( Pt 1)():91-8. PubMed ID: 4040360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced plasminogen activator production by highly metastatic variant cell lines of a rat mammary adenocarcinoma.
    Ramshaw IA; Badenoch-Jones P; Grant A; Maxted M; Claudianos C
    Invasion Metastasis; 1986; 6(3):133-44. PubMed ID: 3733365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An inhibitor of plasminogen activator produced by tumour cell fusion hybrids.
    Badenoch-Jones P; Ramshaw IA; Grant A
    Aust J Exp Biol Med Sci; 1985 Jun; 63 ( Pt 3)():343-52. PubMed ID: 2933023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells.
    Badenoch-Jones P; Ramshaw IA
    Invasion Metastasis; 1984; 4(2):98-110. PubMed ID: 6539758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of cell fusion to analyse factors involved in tumour cell metastasis.
    Ramshaw IA; Carlsen S; Wang HC; Badenoch-Jones P
    Int J Cancer; 1983 Oct; 32(4):471-8. PubMed ID: 6684641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.
    Nakajima M; Welch DR; Belloni PN; Nicolson GL
    Cancer Res; 1987 Sep; 47(18):4869-76. PubMed ID: 3621180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on rat mammary adenocarcinomas: a model for metastasis.
    Ramshaw IA; Badenoch-Jones P
    Cancer Metastasis Rev; 1985; 4(3):195-208. PubMed ID: 3907819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lectin-binding characteristics of related high- and low-metastatic rat mammary adenocarcinoma cell lines.
    Badenoch-Jones P; Claudianos C; Ramshaw IA
    Invasion Metastasis; 1987; 7(5):284-96. PubMed ID: 3679743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An innate host response to the neoplastic cell: syngeneic rat tumor cells can elicit a rapid de novo lymphoid procoagulant response.
    Lando PA; Edgington TS
    J Immunol; 1985 Nov; 135(5):3587-95. PubMed ID: 4045197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification and characterization of an inhibitor of plasminogen activator released by rat mammary adenocarcinoma cells.
    Grant AJ; Ramshaw IA; Badenoch-Jones P; Eichner RD; Hunt NH
    Eur J Biochem; 1986 Feb; 154(3):635-41. PubMed ID: 3081343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 6-thioguanine-resistant variant of the 13762 cell line which is no longer tumorigenic or metastatic.
    Ramshaw IA; Carlsen SA; Hoon D; Warrington RC
    Int J Cancer; 1982 Nov; 30(5):601-7. PubMed ID: 6891375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dengue virus on procoagulant and fibrinolytic activities of monocytes.
    Krishnamurti C; Alving B
    Rev Infect Dis; 1989; 11 Suppl 4():S843-6. PubMed ID: 2501855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of plasminogen activator production with tumor metastasis in a rat model.
    Carlsen SA; Ramshaw IA; Warrington RC
    Cancer Res; 1984 Jul; 44(7):3012-6. PubMed ID: 6539167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of plasminogen activator and inhibition of embryonic cell aggregation by cultured human normal and neoplastic cells.
    Phan Thu A; Popovic M
    Neoplasma; 1979; 26(6):663-75. PubMed ID: 575560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of TGF-beta and TNF-alpha on procoagulant and fibrinolytic pathways of human tracheal epithelial cells.
    Idell S; Kumar A; Zwieb C; Holiday D; Koenig KB; Johnson AR
    Am J Physiol; 1994 Dec; 267(6 Pt 1):L693-703. PubMed ID: 7810674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DMSO-induced changes in the procoagulant and fibrinolytic activity of B16 melanoma cells: influence on lung colony formation.
    Casali B; Lampugnani MG; Riganti M; Niewiarowska A; Alessio G; Mussoni L; Semeraro N; Donati MB
    Clin Exp Metastasis; 1988; 6(5):377-85. PubMed ID: 3378375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between urokinase-type plasminogen activator production and the metastasizing ability of two murine mammary adenocarcinomas.
    Pereyra-Alfonso S; Haedo A; Bal de Kier Joffé E
    Int J Cancer; 1988 Jul; 42(1):59-63. PubMed ID: 3134309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential release of active proteinase inhibitors by two rat mammary adenocarcinoma variants possessing different metastatic potentials.
    Neri A; Bohoslawec O; Anderson TD; Tokes ZA
    Cancer Res; 1991 Feb; 51(4):1318-25. PubMed ID: 1997170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of the production of plasminogen activator with tumor metastasis in B16 mouse melanoma cell lines.
    Wang BS; McLoughlin GA; Richie JP; Mannick JA
    Cancer Res; 1980 Feb; 40(2):288-92. PubMed ID: 7356511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis associated with human neoplasia: production of plasminogen activator by human tumours.
    Nagy B; Ban J; Brdar B
    Int J Cancer; 1977 May; 19(5):614-20. PubMed ID: 863542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.